Maxim Pharmaceuticals Private Limited
About Maxim Pharmaceuticals Private Limited
Data last updated:
Maxim Pharmaceuticals Private Limited is a private limited company based in Pune, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 10 December 1998 and has been in existence for over 28 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U24239PN1998PTC013106. Its GSTIN is 27AABCM8428N1ZY (Maharashtra).
The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹24.5 Lakh. It is led by directors including Ashok Kundanmal Dhoka (Managing Director) and Manju Ashok Dhoka (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Flat No.08 Kshitij Apartments Salisbury Park Opp. Sambhavnath Jain Mandir Gultekadi, Pune, Maharashtra, India – 411037.
As per the financials filed for FY 2025, the company reported a revenue of ₹129.31 Cr, a decline of 6% compared to the previous year. For the same year it recorded a net profit of ₹20.17 Cr (net margin 15.6%) and EBITDA of ₹28.49 Cr (EBITDA margin 22%). Revenue has grown at a compounded annual rate (CAGR) of 9% over three years and 13% over five years.
As per MCA filings, the company has satisfied charges of ₹3.87 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Maxim Pharmaceuticals Private Limited's registered office is in Pune, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressFlat No.08 Kshitij Apartments Salisbury Park Opp. Sambhavnath Jain Mandir Gultekadi, Pune, Maharashtra, India – 411037
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Maxim Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Maxim Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Maxim Pharmaceuticals Private Limited, buy the company report.
Financials of Maxim Pharmaceuticals Private Limited
FY 2025 filings availableMaxim Pharmaceuticals Private Limited reported revenue of ₹129.31 Cr (down 6% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 6% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 13%. EBITDA fell 1% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹28.49 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹20.17 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 22% | ||||
| Net Profit Margin | 15.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Maxim Pharmaceuticals Private Limited, buy the company report.
Board of directors of Maxim Pharmaceuticals Private Limited
Maxim Pharmaceuticals has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ashok Kundanmal Dhoka Also directs: Madhurhealth and Nutrition Private Limited | Managing Director | 10 Dec 1998 | 27 Years 10 Months | Current |
| Tanvir Ahmed Khan Mahadik | Director | 01 Jul 2017 | 9 Years 4 Months | Current |
| Manju Ashok Dhoka Also directs: Madhurhealth and Nutrition Private Limited | Whole-Time Director | 10 Dec 1998 | 27 Years 10 Months | Current |
Peer comparison
Maxim Pharmaceuticals Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Bengal Chemicals and Pharmaceuticals Ltd | ₹132.57 Cr (FY 2024) | 18.0% | Kolkata, West Bengal, India | |||
| Prosperity Drugs Private Limited | ₹131.43 Cr (FY 2025) | -1.0% | Solan, Himachal Pradesh, India | |||
| Dey's Medical Stores (Manufacturing) Ltd | ₹130.35 Cr (FY 2025) | -2.0% | Kolkata, West Bengal, India | |||
| Elder Prroject Limited | ₹129.37 Cr (FY 2022) | 18.0% | Mumbai, Maharashtra, India | |||
| Maxim Pharmaceuticals Private Limitedthis company | ₹129.31 Cr (FY 2025) | ₹20.17 Cr | 15.6% | -6.0% | Pune, Maharashtra, India | |
| Koye Pharmaceuticals Private Limited | ₹129.09 Cr (FY 2025) | -4.0% | Mumbai, Maharashtra, India | |||
| Centurion Remedies Private Limited | ₹128.35 Cr (FY 2025) | -10.0% | Vadodara, Gujarat, India | |||
| Encore Healthcare Private Limited | ₹128.04 Cr (FY 2025) | 2.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Maxim Pharmaceuticals Private Limited, buy the company report.
Auditor
Maxim Pharmaceuticals Private Limited is audited by MUJUMDAR & DIXIT for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| MUJUMDAR & DIXIT | FY 2024 | 122292W |
Shareholding
The shareholding of Maxim Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Maxim Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 22 Sep 2009 | 10180499 | Corporation Bank | ₹3.5 Cr | Satisfied | |
| 02 Aug 1999 | 90091003 | Central Bak of India | ₹37 Lakh | Satisfied |
To see the full charge records of Maxim Pharmaceuticals Private Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Maxim Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Maxim Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Maxim Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AABCM8428N1ZY | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Maxim Pharmaceuticals Private Limited, buy the company report.
Recent activity
Maxim Pharmaceuticals Private Limited has 4 board changes on record since 1998: 3 appointments and 1 cessation. The latest: Tanvir Ahmed Khan Mahadik was appointed as Director on 01 Jul 2017.
1 earlier event is in the company report.
Frequently asked questions
Maxim Pharmaceuticals is an active private limited company based in Pune, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 10 December 1998 (28+ years old) and is registered under CIN U24239PN1998PTC013106.
Maxim Pharmaceuticals has 3 current directors:
- Ashok Kundanmal Dhoka - Managing Director
- Manju Ashok Dhoka - Whole-Time Director
- Tanvir Ahmed Khan Mahadik - Director
The latest financial statements of Maxim Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Maxim Pharmaceuticals is 27AABCM8428N1ZY, registered in Maharashtra.
The CIN (Corporate Identification Number) of Maxim Pharmaceuticals is U24239PN1998PTC013106. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Maxim Pharmaceuticals was incorporated on 10 December 1998, making it 28+ years old. It is registered with the Registrar of Companies, Pune.
The peers of Maxim Pharmaceuticals by revenue are Bengal Chemicals and Pharmaceuticals Ltd, Prosperity Drugs Private Limited, Dey's Medical Stores (Manufacturing) Ltd, Elder Prroject Limited, Koye Pharmaceuticals Private Limited and 2 more, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Tanvir Ahmed Khan Mahadik was appointed as Director on 01 Jul 2017. Tanvir Ahmed Khan Mahadik ceased to be Additional Director on 01 Jul 2017. Ashok Kundanmal Dhoka was appointed as Managing Director on 10 Dec 1998. Maxim Pharmaceuticals has 4 board changes on record in total.
The registered office of Maxim Pharmaceuticals is at Flat No.08 Kshitij Apartments Salisbury Park Opp. Sambhavnath Jain Mandir Gultekadi, Pune, Maharashtra, India – 411037.
Maxim Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.
Maxim Pharmaceuticals has no open charges and satisfied charges of ₹3.87 Cr as per latest MCA filings.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
